These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29911269)

  • 1. Exploring the Lead Compounds for Zika Virus NS2B-NS3 Protein: an e-Pharmacophore-Based Approach.
    Rohini K; Agarwal P; Preethi B; Shanthi V; Ramanathan K
    Appl Biochem Biotechnol; 2019 Jan; 187(1):194-210. PubMed ID: 29911269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zika virus NS2B/NS3 proteinase: A new target for an old drug - Suramin a lead compound for NS2B/NS3 proteinase inhibition.
    Coronado MA; Eberle RJ; Bleffert N; Feuerstein S; Olivier DS; de Moraes FR; Willbold D; Arni RK
    Antiviral Res; 2018 Dec; 160():118-125. PubMed ID: 30393012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of NS2B-NS3 Protease Inhibitors for Therapeutic Application in ZIKV Infection: A Pharmacophore-Based High-Throughput Virtual Screening and MD Simulations Approaches.
    Rehman HM; Sajjad M; Ali MA; Gul R; Irfan M; Naveed M; Bhinder MA; Ghani MU; Hussain N; Said ASA; Al Haddad AHI; Saleem M
    Vaccines (Basel); 2023 Jan; 11(1):. PubMed ID: 36679976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Structure of the Zika Virus Protease, NS2B/NS3
    Hilgenfeld R; Lei J; Zhang L
    Adv Exp Med Biol; 2018; 1062():131-145. PubMed ID: 29845530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D-QSAR pharmacophore-based virtual screening, molecular docking and molecular dynamics simulation toward identifying lead compounds for NS2B-NS3 protease inhibitors.
    Luo PH; Zhang XR; Huang L; Yuan L; Zhou XZ; Gao X; Li LS
    J Recept Signal Transduct Res; 2017 Oct; 37(5):481-492. PubMed ID: 28758854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the Zika virus two-component NS2B-NS3 protease and structure-assisted identification of allosteric small-molecule antagonists.
    Shiryaev SA; Farhy C; Pinto A; Huang CT; Simonetti N; Elong Ngono A; Dewing A; Shresta S; Pinkerton AB; Cieplak P; Strongin AY; Terskikh AV
    Antiviral Res; 2017 Jul; 143():218-229. PubMed ID: 28461069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Insights into the Inhibition of Zika Virus NS2B-NS3 Protease by a Small-Molecule Inhibitor.
    Li Y; Zhang Z; Phoo WW; Loh YR; Li R; Yang HY; Jansson AE; Hill J; Keller TH; Nacro K; Luo D; Kang C
    Structure; 2018 Apr; 26(4):555-564.e3. PubMed ID: 29526431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction.
    Li Z; Brecher M; Deng YQ; Zhang J; Sakamuru S; Liu B; Huang R; Koetzner CA; Allen CA; Jones SA; Chen H; Zhang NN; Tian M; Gao F; Lin Q; Banavali N; Zhou J; Boles N; Xia M; Kramer LD; Qin CF; Li H
    Cell Res; 2017 Aug; 27(8):1046-1064. PubMed ID: 28685770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solution conformations of Zika NS2B-NS3pro and its inhibition by natural products from edible plants.
    Roy A; Lim L; Srivastava S; Lu Y; Song J
    PLoS One; 2017; 12(7):e0180632. PubMed ID: 28700665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico evaluation of inhibitory potential of triterpenoids from Azadirachta indica against therapeutic target of dengue virus, NS2B-NS3 protease.
    Dwivedi VD; Tripathi IP; Mishra SK
    J Vector Borne Dis; 2016; 53(2):156-61. PubMed ID: 27353586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel small molecule inhibitors against NS2B/NS3 serine protease from Zika virus.
    Lee H; Ren J; Nocadello S; Rice AJ; Ojeda I; Light S; Minasov G; Vargas J; Nagarathnam D; Anderson WF; Johnson ME
    Antiviral Res; 2017 Mar; 139():49-58. PubMed ID: 28034741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of unlinked NS2B-NS3 protease from Zika virus.
    Zhang Z; Li Y; Loh YR; Phoo WW; Hung AW; Kang C; Luo D
    Science; 2016 Dec; 354(6319):1597-1600. PubMed ID: 27940580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased activity of unlinked Zika virus NS2B/NS3 protease compared to linked Zika virus protease.
    Kuiper BD; Slater K; Spellmon N; Holcomb J; Medapureddy P; Muzzarelli KM; Yang Z; Ovadia R; Amblard F; Kovari IA; Schinazi RF; Kovari LC
    Biochem Biophys Res Commun; 2017 Oct; 492(4):668-673. PubMed ID: 28342876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solution conformations of a linked construct of the Zika virus NS2B-NS3 protease.
    Mahawaththa MC; Pearce BJG; Szabo M; Graham B; Klein CD; Nitsche C; Otting G
    Antiviral Res; 2017 Jun; 142():141-147. PubMed ID: 28336347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of potential Zika virus NS2B-NS3 protease inhibitors via docking, molecular dynamics and consensus scoring-based virtual screening.
    Bowen LR; Li DJ; Nola DT; Anderson MO; Heying M; Groves AT; Eagon S
    J Mol Model; 2019 Jun; 25(7):194. PubMed ID: 31209577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lead Optimization Studies Towards Finding NS2B/NS3 Protease Targetspecific Inhibitors as Potential Anti-dengue Drug-like Compounds.
    Gurusamy M; Abdul JF
    Curr Drug Discov Technol; 2019; 16(3):307-314. PubMed ID: 29984660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substrate profiling of Zika virus NS2B-NS3 protease.
    Gruba N; Rodriguez Martinez JI; Grzywa R; Wysocka M; Skoreński M; Burmistrz M; Łęcka M; Lesner A; Sieńczyk M; Pyrć K
    FEBS Lett; 2016 Oct; 590(20):3459-3468. PubMed ID: 27714789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural Dynamics of Zika Virus NS2B-NS3 Protease Binding to Dipeptide Inhibitors.
    Li Y; Zhang Z; Phoo WW; Loh YR; Wang W; Liu S; Chen MW; Hung AW; Keller TH; Luo D; Kang C
    Structure; 2017 Aug; 25(8):1242-1250.e3. PubMed ID: 28689970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-guided Discovery of a Novel Non-peptide Inhibitor of Dengue Virus NS2B-NS3 Protease.
    Li L; Basavannacharya C; Chan KW; Shang L; Vasudevan SG; Yin Z
    Chem Biol Drug Des; 2015 Sep; 86(3):255-64. PubMed ID: 25533891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of potential inhibitors of Zika virus targeting NS3 helicase using molecular dynamics simulations and DFT studies.
    Mishra SS; Kumar N; Karkara BB; Sharma CS; Kalra S
    Mol Divers; 2023 Aug; 27(4):1689-1701. PubMed ID: 36063275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.